BNP/CALL/NOVONESIS B/380/0.1/20.09.24 Stock

Warrant

DE000PC39JF7

Real-time Boerse Frankfurt Warrants 08:21:08 2024-05-17 EDT
0.9 EUR +7.14% Intraday chart for BNP/CALL/NOVONESIS B/380/0.1/20.09.24
Current month+61.54%
1 month+82.61%
Date Price Change
24-05-17 0.9 +7.14%
24-05-16 0.84 +3.70%
24-05-15 0.81 +3.85%
24-05-14 0.78 -1.27%
24-05-13 0.79 +5.33%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 08:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVONESIS A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC39JF
ISINDE000PC39JF7
Date issued 2024-01-31
Strike 380 kr
Maturity 2024-09-20 (126 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.25
Spread 0.02
Spread %2.15%

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
432.3 DKK
Average target price
437.4 DKK
Spread / Average Target
+1.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW